1921
Volume 50, Issue 4_Suppl
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
USD

Abstract

Abstract

Studies indicate that adjuvant formulations based on liposomes, nontoxic lipid A, and muramyl peptide derivatives are safe and effective for vaccine use. Future research on the immunobiology of these adjuvants as well as the mechanisms by which adjuvants can alter the quality of immune responses may play an important role in determining their efficacy in malaria vaccines.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.1994.50.41
1994-04-01
2017-11-24
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.1994.50.41
Loading

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error